CRYOPDP managed the temperature-controlled transport of tumour samples to testing laboratories for the phase 3 XPORT-EC-042 trial.
Published
Signal category
Research & Knowledge
Quote
“The phase 3 XPORT-EC-042 trial tested weekly selinexor as maintenance treatment for people with TP53 wild-type advanced or recurrent endometrial cancer.”
— CRYOPDP team
Company
CRYOPDP
Lifescience & Healthcare Supply Chain Solutions
- Industry
- Transportation, Logistics, Supply Chain and Storage
- Location
- Roissy Charles de Gaulle cedex | France, FR
- Company size
- 341 employees
Everything began with a commitment to serve the life sciences and healthcare industries by offering global transport and innovative temperature-controlled logistics solutions. Being one of the market leaders in our sector and dedicated to the clinical trial and cell & gene therapy communities, we are operating in more than 150 countries intending to improve the health of people around the world. Truly focused on our customer and patient needs, we, through a dedicated team, plan, manage and implement a tailor-made temperature-controlled solution to fit your requirements and business goals. Count on us to deliver your life-saving goods worldwide - Count on CRYOPDP!